Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-491.31%
operating margin TTM
-497.25%
revenue TTM
12.17 Million
revenue per share TTM
0.96$
valuation ratios | |
|---|---|
| pe ratio | -1.59 |
| peg ratio | -0.16 |
| price to book ratio | 2.08 |
| price to sales ratio | 7.81 |
| enterprise value multiple | -2.26 |
| price fair value | 2.08 |
profitability ratios | |
|---|---|
| gross profit margin | 25.13% |
| operating profit margin | -497.25% |
| pretax profit margin | -491.31% |
| net profit margin | -491.31% |
| return on assets | -86.31% |
| return on equity | -102.03% |
| return on capital employed | -107.42% |
liquidity ratios | |
|---|---|
| current ratio | 3.66 |
| quick ratio | 3.45 |
| cash ratio | 3.25 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 106.37 |
| operating cycle | 107.99 |
| days of payables outstanding | 121.73 |
| cash conversion cycle | -13.74 |
| receivables turnover | 225.00 |
| payables turnover | 3.00 |
| inventory turnover | 3.43 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.21 |
| debt equity ratio | 0.32 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.24 |
| interest coverage | -72.82 |
| cash flow to debt ratio | -3.38 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.79 |
| cash per share | 0.67 |
| operating cash flow per share | -0.78 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -3.38 |
| short term coverage ratios | -12.62 |
| capital expenditure coverage ratio | -138.17 |
Frequently Asked Questions
When was the last time CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) reported earnings?
CollPlant Biotechnologies Ltd. (CLGN) published its most recent earnings results on 26-11-2025.
What is CollPlant Biotechnologies Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. CollPlant Biotechnologies Ltd. (NASDAQ:CLGN)'s trailing twelve months ROE is -102.03%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. CollPlant Biotechnologies Ltd. (CLGN) currently has a ROA of -86.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CLGN's net profit margin stand at?
CLGN reported a profit margin of -491.31% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CLGN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.66 in the most recent quarter. The quick ratio stood at 3.45, with a Debt/Eq ratio of 0.32.